Pamishield signs KRW 1.3B supply deal with UCB Pharma

Pamishield has signed a contract with UCB PHARMA S.A. to supply the pharmaceutical intermediate mPEG. The contract is valued at KRW 1,325,300,000 and runs until June 29, 2020.

“파미셀은 UCB PHARMA S.A.와 의약중간체 mPEG 공급계약을 체결했다고 10일 공시했다.”biz.heraldcorp.com

• 1 source
• biz.heraldcorp.com파미셀, 13억 규모 의약중간체 공급계약 체결 - 헤럴드경제김지현1Jan 10, 2020

Summarized from public sources; check the original articles before acting on it.